English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

AbbVie reports early trial results for weight loss drug ABBV-295
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Hansoh reports positive Phase 3 results for obesity drug olatorepatide in China
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Roche reports breast cancer drug giredestrant fails key Phase 3 trial
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Novo Nordisk to sell GLP-1 drugs through Hims & Hers after ending legal dispute
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Xenon to seek approval of first-in-class epilepsy drug after exceeding Phase 3 expectations

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns